The German drugmaker CureVac says its COVID-19 vaccine showed an efficacy of just 47% in a large clinical trial. The disappointing result is just below the 50% threshold set by the World Health Organization and far below the roughly 95% effectiveness shown by other mRNA vaccines produced by Pfizer and Moderna.
Topics:
Top